Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis

about

Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis

Item

http://www.wikidata.org/entity/Q37288061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of adefovir dipivoxil o ...... epatitis B and hepatocirrhosis

@en

Effect of adefovir dipivoxil o ...... patitis B and hepatocirrhosis.

@nl

type

Item

label

Effect of adefovir dipivoxil o ...... epatitis B and hepatocirrhosis

@en

Effect of adefovir dipivoxil o ...... patitis B and hepatocirrhosis.

@nl

prefLabel

Effect of adefovir dipivoxil o ...... epatitis B and hepatocirrhosis

@en

Effect of adefovir dipivoxil o ...... patitis B and hepatocirrhosis.

@nl

P1476

Effect of adefovir dipivoxil o ...... epatitis B and hepatocirrhosis

@en

P2093

Fu Huang

http://www.w3.org/2001/XMLSchema#string

Liting Tian

http://www.w3.org/2001/XMLSchema#string

Qilin Fu

http://www.w3.org/2001/XMLSchema#string

P2860

T cell responses in hepatitis C virus infection: historical overview and goals for future research

Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.

Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection

A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice

Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy.

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy

Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.

Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination

Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?

Immunology in the liver--from homeostasis to disease.

P304

2511-2514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2016.3623

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698751

http://www.w3.org/2001/XMLSchema#string

P921

adefovir dipivoxil

adefovir

P932

5038382

http://www.w3.org/2001/XMLSchema#string